Sign up
Quantellect · Congress · Trade Detail
NASDAQ: VRTXVertex Pharmaceuticals Inc
DemocratHouse

Ro Khanna bought Vertex Pharmaceuticals Inc (NASDAQ: VRTX)

Ro Khanna (D-CA), a U.S. Representative, has disclosed 37 trades in Vertex Pharmaceuticals Inc (VRTX) since 2017, 18 purchases and 19 sales, worth an estimated $378K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Ro Khanna bought $1,001 - $15,000 of Vertex Pharmaceuticals Inc (NASDAQ: VRTX) on February 25, 2025. Since that trade, VRTX is up +0.62% against the S&P 500 up +24.54%, an outperformance of -23.92%.

Across these filings, Ro Khanna has been a net seller of VRTX (a buy-to-sell ratio of 0.95). The most recent disclosed VRTX transaction shown was dated June 2, 2026. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

VRTX trades
37
Disclosed Vol
$378K
Buys
18
49%
Sells
19
51%
Buy / Sell
0.95
ratio
First → Last
2017–2026

Ro Khanna's VRTX trades vs the price

VRTX is up +0.62% since Ro Khanna bought on February 25, 2025, versus +24.54% for the S&P 500.

Performance since this trade

Price change since trade
+0.62%
S&P 500 change since trade
+24.54%
Outperformance vs S&P 500
-23.92%

All Ro Khanna VRTX trades

TradedTypeSizeReturnEst. profit
June 2, 2026BUY$425.09+13.70%+$1K
May 27, 2026SELL$437.22+10.55%
April 24, 2026BUY$430.29+12.33%+$986
April 13, 2026BUY$440.05+9.84%+$787
March 30, 2026SELL$443.16+9.06%
March 23, 2026BUY$451.24+7.11%+$569
February 5, 2026SELL$458.81+5.34%
January 29, 2026BUY$475.68+1.61%+$523
January 23, 2026BUY$468.41+3.19%+$255
October 7, 2025BUY$410.28+17.80%+$1K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Ro Khanna & VRTX trading FAQ

Is it legal for Ro Khanna to trade Vertex Pharmaceuticals Inc (VRTX) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Vertex Pharmaceuticals Inc (VRTX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Ro Khanna buy VRTX?

Ro Khanna disclosed a purchase of $1,001 - $15,000 of Vertex Pharmaceuticals Inc (VRTX) on February 25, 2025, according to public STOCK Act filings.

How has VRTX performed since Ro Khanna's trade?

Since Ro Khanna bought VRTX on February 25, 2025, the stock is up +0.62%, versus +24.54% for the S&P 500 over the same period, an outperformance of -23.92%.

How many times has Ro Khanna traded VRTX?

Ro Khanna has disclosed 37 VRTX trades since 2017 (18 purchases and 19 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional VRTX trades?

Quantellect tracks every disclosed congressional trade in Vertex Pharmaceuticals Inc (VRTX) on the Vertex Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.

Ro Khanna's VRTX tradesAll congressional filings for Vertex Pharmaceuticals IncRo Khanna's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.